ARC-19499

DB15285Investigational

ARC-19499 is under investigation in clinical trial NCT01191372 (First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients).

Mechanism: Pharmacologically active on Tissue factor pathway inhibitor
Curator reviewed
Also known as: BAX499
Code names: ARC19499

Resolves to

Compound

UNII0493WH50VTCAS1350667-54-7

Targets

P10646TFPI

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with ARC-19499, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account